QuriousRI-GP – Regulatory Strategy and Planning Tool
Services We Offer
QuriousRI-GP – Leading Regulatory Strategy & Planning Platform
Simulate diverse and complex regulatory scenarios across leading markets worldwide for your pharmaceutical, biologics, medical devices, radipharmceutical and combination products. Leverage Artixio’s regulatory intelligence database, QuriousRI, latest regulatory updates, analysis of regulatory pathways in key markets for all applications (new drugs, abbreviated pathways, lifecycle, paediatric, orphan drug), documentation requirements based on reference drugs / predicate products approved in the target markets. Build your regulatory roadmap seamlessly with Artixio expert driven regulatory insights.
Visualize Your Regulatory Strategy
| Verify Novelty | Analyse competitor drugs approved in the target markets to establish novelty |
| Define Pathway | Assess applicable pathways based on local regulations and reference / predicate products |
| Assess Requirements | Deep dive into regulatory requirements following the pathway including local testing, characterization and stability requirements |
| Assess Documentation | Surf the comprehensive list of documents required per regulatory requirements including those requiring translation and legalization |
| Compare | Streamline your global strategy comparing pathways and documentation required across multiple countries |
| Mitigate Gaps | Use your approved or existing dossier against target market requirements to find gaps. Leverage Artixio’s insights for mitigation of gaps |
Global Product Lifecycle and Portfolio Management Dashboard
Regulator Intelligence Agents
FAQs
What are the features of QuriousRI-GP?
QuriousRI-GP offers end to end life sciences (pharma, devices, biologics etc.) product lifecycle management strategy and planning solutions to prepare submission documents for health authorities worldwide. It also helps tracking the products status worldwide from planning to gap analysis, dossier preparation, submission, approval and post approval lifecycle maintenance. It offers assessment of reference and predicate products in the markets, applicable regulatory pathways, regulatory requirements in target countries, documentation requirements, comparison of multiple countries and perform gap analysis of documents.
Which countries are covered in the QuriousRI-GP?
How does the regulatory intelligence work in the tool?
Industries We Serve
Our Global Reach: Serving Life
Sciences Clients Worldwide

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

Europe

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea
Insights from Artixio - Tips & Article
Orphan Drug Designation in
Orphan Drug Designation (ODD) is regulated by Ministry of Food and Drug Safety (MFDS)...
Artificial Intelligence (AI) and
Artificial Intelligence (AI) and Machine Learning (ML) in drug discovery offer new possibilities for...
Competitive Intelligence for a
Artixio’s competitive intelligence experts are seasoned in developing comprehensive strategy across therapeutic areas, treatment...